Genotype-guided tacrolimus dosing in African-American kidney transplant recipients.

MLA

Sanghavi, K., et al. “Genotype-Guided Tacrolimus Dosing in African-American Kidney Transplant Recipients.” The Pharmacogenomics Journal, vol. 17, no. 1, Jan. 2017, pp. 61–68. EBSCOhost, https://doi.org/10.1038/tpj.2015.87.

APA

Sanghavi, K., Brundage, R. C., Miller, M. B., Schladt, D. P., Israni, A. K., Guan, W., Oetting, W. S., Mannon, R. B., Remmel, R. P., Matas, A. J., & Jacobson, P. A. (2017). Genotype-guided tacrolimus dosing in African-American kidney transplant recipients. The Pharmacogenomics Journal, 17(1), 61–68. https://doi.org/10.1038/tpj.2015.87

Chicago

Sanghavi, K, R C Brundage, M B Miller, D P Schladt, A K Israni, W Guan, W S Oetting, et al. 2017. “Genotype-Guided Tacrolimus Dosing in African-American Kidney Transplant Recipients.” The Pharmacogenomics Journal 17 (1): 61–68. doi:10.1038/tpj.2015.87.